Fauci Defends FDA for Rescinding Authorization of Monoclonal Antibodies -- 'Risk of a Potential Adverse Effect with Essentially No Benefit'

National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci on Tuesday defended the Food and Drug Administration's decision to rescind emergency-use authorizations for two monoclonal treatments used for the coronavirus.